AAV9 gene therapy rescues a murine model of Menkes disease

被引：0
|
作者：
Kaler, Stephen G. [1 ]
Donsante, Anthony [1 ]
Haddad, Marie-Reine [1 ]
机构：
[1] NICHD, Program Mol Med, NIH, Bethesda, MD USA
来源：
HUMAN GENE THERAPY | 2011年 / 22卷 / 10期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：A77 / A78
页数：2
相关论文
共 50 条
  • [21] Gene therapy for the CNS using AAVs: The impact of systemic delivery by AAV9
    Saraiva, Joana
    Nobre, Rui Jorge
    de Almeida, Luis Pereira
    JOURNAL OF CONTROLLED RELEASE, 2016, 241 : 94 - 109
  • [22] Combined Brain-Directed Recombinant Adeno-Associated Virus Gene Therapy and Copper Rescues a Murine Model of Severe Menkes Disease
    Donsante, Anthony
    Tang, Jingrong
    Brinster, Lauren R.
    Holmes, Courtney S.
    Goldstein, David S.
    Centeno, Jose A.
    Kaler, Stephen G.
    MOLECULAR THERAPY, 2009, 17 : S150 - S150
  • [23] Systemic AAV9 Gene Therapy Rescues Propionic Acidemia (PA) Mice from Neonatal Lethality and Provides Sustained Therapeutic Benefits
    Li, Lina
    Choi, Eun-Young
    Head, Pam S.
    Myung, Sam
    Smith, Stephanie
    Wagner, Erik
    Wang, Amy
    Chen, Catherine
    Xu, Xin
    Ottinger, Elizabeth
    Lo, Donald
    Brooks, Philip J.
    Chandler, Randy J.
    Venditti, Charles P.
    MOLECULAR THERAPY, 2021, 29 (04) : 120 - 120
  • [24] AAV9 Vector: a Novel modality in gene therapy for spinal muscular atrophy
    Pattali, Rithu
    Mou, Yongchao
    Li, Xue-Jun
    GENE THERAPY, 2019, 26 (7-8) : 287 - 295
  • [25] Improved AAV1 and AAV9 Vectors for Gene Delivery
    Balakrishnan, Balaji
    Krishnagopal, Akshaya
    Sen, Dwaipayan
    Srivastava, Alok
    Jayandharan, Giridhara R.
    MOLECULAR THERAPY, 2013, 21 : S130 - S131
  • [26] AAV9 Gene Therapy Increases Lifespan and Treats Pathological and Behavioral Abnormalities in a Mouse Model of CLN8-Batten Disease
    Johnson, Tyler B.
    White, Katherine A.
    Brudvig, Jon J.
    Cain, Jacob T.
    Langin, Logan
    Pratt, Melissa A.
    Booth, Clarissa D.
    Timm, Derek J.
    Davis, Samantha S.
    Meyerink, Brandon
    Likhite, Shibi
    Meyer, Kathrin
    Weimer, Jill M.
    MOLECULAR THERAPY, 2021, 29 (01) : 162 - 175
  • [27] CNS-Directed AAV9 Gene Therapy for the Treatment of Canine Globoid Cell Leukodystrophy (Krabbe Disease)
    Bradbury, Allison M.
    Bagel, Jessica H.
    Hendricks, Ian J.
    Duc Nguyen
    Bongarzone, Ernesto R.
    Gray, Steven J.
    Vite, Charles H.
    MOLECULAR THERAPY, 2019, 27 (04) : 189 - 189
  • [28] Intrathecal delivery of a bicistronic AAV9 vector expressing β-hexosaminidase A corrects Sandhoff disease in a murine model: A dosage study
    Ryckman, Alex E.
    Deschenes, Natalie M.
    Quinville, Brianna M.
    Osmon, Karlaina J. L.
    Mitchell, Melissa
    Chen, Zhilin
    Gray, Steven J.
    Walia, Jagdeep S.
    MOLECULAR THERAPY METHODS & CLINICAL DEVELOPMENT, 2024, 32
  • [29] AAV based gene therapy rescues the murine cardiac phenotype associated with Friedreich ataxia
    Perdomini, Morgane
    Belbellaa, Brahim
    Monassier, Laurent
    Cartier, Nathalie
    Aubourg, Patrick
    Puccio, Helene
    HUMAN GENE THERAPY, 2012, 23 (10) : A43 - A44
  • [30] Transduction of choroid plexus epithelia is crucial for gene therapy rescue in a murine model of Menkes disease
    Donsante, A.
    Yi, L.
    Zerfas, P.
    Brinster, L.
    Sullivan, P.
    Goldstein, D.
    Prohaska, J.
    Centeno, J.
    Kaler, S. G.
    HUMAN GENE THERAPY, 2010, 21 (10) : 1425 - 1426
12345